🔎 Trials Near Me

Home › Type 1 Diabetes › Illinois

Pag-aaral pangklinika para sa Type 1 Diabetes sa Illinois

16 pag-aaral para sa Type 1 Diabetes ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • Ann & Robert H. Lurie Children's Hospital, Chicago
  • Northwestern University, Chicago
  • Southern Illinois University School of Medicine, Springfield
Nagre-recruitPhase 1/2
Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06783309

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  • University of Chicago, Chicago
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04786262

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

  • University of Illinois Hospital & Health Sciences System, Chicago
Nagre-recruitPhase 1/2
Edad 35 hanggang 70 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06575426

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Northwestern University, Chicago
Nagre-recruit
Edad 14 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07579702

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

  • Northwestern University, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07676565

Circadian Mechanisms, Glucose, and CV Risks in T1D

  • University of Illinois Chicago, Chicago
Nagre-recruit
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06624046

Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

  • Illinois Institute of Technology, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT07650682

A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers

  • Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
Nagre-recruit
Edad 14 hanggang 18 · Lahat ng kasarian · Na-update May 29, 2026 · NCT06709755

Kidney Precision Medicine Project

  • University of Illinois Chicago, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT04334707

Registry for Stage 2 Type 1 Diabetes

  • University of Chicago Medical Center- Site Number : 8400017, Chicago
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06481904

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

  • University of Chicago Medical Center, Chicago
Nagre-recruitPhase 2
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Abr 6, 2026 · NCT06964087

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Northwestern University Feinberg School of Medicine, Chicago
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT06217302

CBTi for the Treatment of Insomnia in Type 1 Diabetes

  • University of Illinois Chicago, Chicago
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT07091318

Type 1 Diabetes and Obstructive Sleep Apnea

  • University of Chicago, Chicago
Nagre-recruit
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06915831

Islet Transplantation in Patients With "Brittle" Type I Diabetes

  • University of Chicago Medical Center, Chicago
Nagre-recruit
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Dis 9, 2025 · NCT01630850

Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • The University of Chicago, Chicago
Nagre-recruitPhase 2
Edad 18 hanggang 68 · Lahat ng kasarian · Na-update Dis 8, 2025 · NCT01241864

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.